Corporate Banner
Satellite Banner
Technology Networks Header
Monday, July 28, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
New Test for Cancer Researchers Targets Important Tumor-Suppressor Protein
Tuesday, September 10, 2013
Highly sensitive test gives researchers a more sophisticated tool to assess PTEN protein expression in cancer cells.

Abcam Launches SimpleStep ELISA Kits
Monday, September 09, 2013
Kits offer enhanced performance and ease of use to accelerate immunoassay research.

Genalyte and Barbara Davis Diabetes Center Collaborate
Friday, August 16, 2013
Genalyte launches multiplexed biomarker panel that measures seven autoantigens associated with the development of T1D.

Cronus Technologies Launches the Handyem HPC-100 Portable Flow Cytometer
Wednesday, August 14, 2013
Company launches HPC-100 at Flow Cytometry UK 2013.

WHEATON® Offers a Turnkey Solution for CHO Cell Bioproduction
Wednesday, August 07, 2013
WHEATON® CELLine™ Bioreactor combined with an optimized CHO medium formulation by Irvine Scientific expedites small-scale antibody and protein production.

Apeiron and Rentschler Announces Partnership Agreement
Friday, August 02, 2013
Rentschler produces Apeiron's monoclonal antibody APN311 for late stage clinical development and market.

Medix Biochemica Launches MedixMAB by Design™ at AACC 2013
Monday, July 29, 2013
Highest quality recombinant antibody production service to ensure superior IVD tests.

New Norovirus Monoclonal Antibodies
Monday, July 15, 2013
Two new sets of MONOTOPE™ monoclonal antibodies from ViroStat.

BioVendor Benefits from Using SCIENION’s Integrated Product Portfolio
Tuesday, July 09, 2013
Combined sciDROP PICO and sciDROP NANO technologies used for developing multiplex tests in microtiter plates.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 344
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv